Fig. 2From: Increased CX3CL1 in cerebrospinal fluid and ictal serum t-tau elevations in migraine: results from a cross-sectional exploratory case-control studyBox plots of markers of axonal damage. The median and IQR of NfL, GFAP, and UCHL1 concentrations in pg/ml in CSF (upper row) and serum (lower row) of the 3 different cohorts are presented. There is no significant difference in any protein concentration, neither in serum nor in CSF, between the interictal, the ictal-collected sample of migraine patients, or the control cohort of non-migraine patients (for all p > 0.05)Back to article page